Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CA12 | O43570 | 1/20 | 0.34 |
| ▸ | CA1 | P00915 | 1/20 | 0.34 |
| ▸ | CA2 | P00918 | 1/20 | 0.34 |
| ▸ | CA9 | Q16790 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | SPHK1 | Q9NYA1 | 2/20 | 0.34 |
| ▸ | LPAR3 | Q9UBY5 | 6/20 | 0.33 |
| ▸ | LPAR2 | Q9HBW0 | 5/20 | 0.33 |
| ▸ | LPAR1 | Q92633 | 2/20 | 0.33 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.33 |
| ▸ | NAAA | Q02083 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22102 | 0.93 | TSHR (0.34) | USP2HTTSPHK1GPR84CYP3A4 | |
| SCHEMBL20898883 | 0.77 | TSHR (0.42) | USP2HTTCYP3A4 | |
| SCHEMBL8093873 | 0.77 | DNM1 (0.43) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL1607078 | 0.76 | DNM1 (0.47) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL6379210 | 0.76 | DNM1 (0.47) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL23038685 | 0.76 | DNM1 (0.47) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL891413 | 0.76 | DNM1 (0.47) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL3281118 | 0.75 | TSHR (0.40) | CYP3A4 | |
| SCHEMBL28101338 | 0.75 | HTT (0.46) | USP2HTTMEN1THRBKMT2A | |
| SCHEMBL11130083 | 0.74 | GPR84 (0.44) | HTTMAPTSPHK1GPR84CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260027750-A1 | Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products | DOW GLOBAL TECHNOLOGIES LLC (US) | 2026-01-29 | — | — | US | claimed |
| US-11613045-B2 | Continuous extruder process for manufacturing rheology-modified polyolefin for cable insulation layer, and related products | DOW GLOBAL TECHNOLOGIES LLC (US) | 2023-03-28 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260027750-A1 | Continuous Extruder Process for Manufacturing Rheology-Modified Polyolefin for Cable Insulation Layer, and Related Products | SEC16A, RBM17, IDE | USP2 2481/4885HTT 966/4885MEN1 815/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.